关键词: font-size:medium, ">变应性鼻炎；安脱达屋尘螨变应原疫苗；低温等离子；特异性免疫治疗

Abstract: Objective： To compare and analyze the efficacy of alutard house dust mite allergens vaccine and low-temperature plasma in the treatment of allergic rhinitis. Methods： 88 patients with allergic rhinitis admitted in our hospital from January 2018 to December 2019 were selected as the research objects. According to the computer randomization method， they were divided into two groups： the study group and the routine group， with 44 patients in each group. Patients in the routine group were treated with low-temperature plasma treatment， and patients in the study group were treated with alutard house dust mite allergens vaccine injection. The clinical treatment effects of the two groups of patients were compared and analyzed. Results： The clinical efficacy of patients in the study group (93.18%) was higher than that of the routine group (79.55%) (P＜0.05). Before treatment， there was no significant difference in clinical symptom scores between the two groups (P>0.05). After treatment， the clinical symptom scores of both two groups reduced. And the reduction in the study group was more obvious(P＜0.05). The total incidence of adverse reactions in the study group was 6.82%， which was lower than that in the routine group (27.27%)(P＜0.05). Conclusion： Compared with low-temperature plasma treatment of allergic rhinitis， alutard house dust mite allergens vaccine injection has better clinical effect in the treatment of allergic rhinitis， which can alleviate the clinical symptoms of patients， and has fewer adverse reactions and higher safety.
   

Key words: font-size:medium, ">Allergic rhinitis； Alutard house dust mite allergens vaccine； Low-temperature plasma； Specific immunotherapy